KRON logo

Kronos Bio (KRON) Company Overview

Profile

Full Name:

Kronos Bio, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 9, 2020

Indexes:

Not included

Description:

Kronos Bio is a biotechnology company focused on developing innovative treatments for cancer. They use advanced science to understand how cancer cells work and create targeted therapies that aim to improve patient outcomes. Their goal is to provide new options for patients with difficult-to-treat cancers.

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 19, 24 HC Wainwright & Co.
Buy
Aug 1, 24 HC Wainwright & Co.
Buy
May 3, 24 HC Wainwright & Co.
Buy
Dec 19, 23 Piper Sandler
Overweight
Dec 19, 23 HC Wainwright & Co.
Buy
Nov 27, 23 HC Wainwright & Co.
Buy
Aug 21, 23 HC Wainwright & Co.
Buy
Apr 17, 23 HC Wainwright & Co.
Buy
Nov 18, 22 HC Wainwright & Co.
Buy
Nov 10, 22 Goldman Sachs
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Kronos Bio?
  • Does Kronos Bio pay dividends?
  • What sector is Kronos Bio in?
  • What industry is Kronos Bio in?
  • What country is Kronos Bio based in?
  • When did Kronos Bio go public?
  • Is Kronos Bio in the S&P 500?
  • Is Kronos Bio in the NASDAQ 100?
  • Is Kronos Bio in the Dow Jones?
  • When was Kronos Bio's last earnings report?
  • When does Kronos Bio report earnings?
  • Should I buy Kronos Bio stock now?

What is the ticker symbol for Kronos Bio?

The ticker symbol for Kronos Bio is NASDAQ:KRON

Does Kronos Bio pay dividends?

No, Kronos Bio does not pay dividends

What sector is Kronos Bio in?

Kronos Bio is in the Healthcare sector

What industry is Kronos Bio in?

Kronos Bio is in the Biotechnology industry

What country is Kronos Bio based in?

Kronos Bio is headquartered in United States

When did Kronos Bio go public?

Kronos Bio's initial public offering (IPO) was on October 9, 2020

Is Kronos Bio in the S&P 500?

No, Kronos Bio is not included in the S&P 500 index

Is Kronos Bio in the NASDAQ 100?

No, Kronos Bio is not included in the NASDAQ 100 index

Is Kronos Bio in the Dow Jones?

No, Kronos Bio is not included in the Dow Jones index

When was Kronos Bio's last earnings report?

Kronos Bio's most recent earnings report was on Nov 13, 2024

When does Kronos Bio report earnings?

The next expected earnings date for Kronos Bio is Mar 21, 2025

Should I buy Kronos Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions